electroCore to Participate at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21
electroCore (Nasdaq: ECOR), a bioelectronic medicine and wellness company, announced its participation in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on November 21, 2024 in New York City. Joshua Lev, Chief Financial Officer, will be available for one-on-one meetings throughout the event. Interested investors can arrange meetings through their Canaccord Genuity representatives.
electroCore (Nasdaq: ECOR), un'azienda attiva nella medicina bioelettronica e nel benessere, ha annunciato la sua partecipazione al Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum che si terrà il 21 novembre 2024 a New York City. Joshua Lev, Direttore Finanziario, sarà disponibile per incontri individuali per tutta la durata dell'evento. Gli investitori interessati possono organizzare incontri tramite i loro rappresentanti di Canaccord Genuity.
electroCore (Nasdaq: ECOR), una compañía de medicina bioelectrónica y bienestar, anunció su participación en el Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum el 21 de noviembre de 2024 en la ciudad de Nueva York. Joshua Lev, Director Financiero, estará disponible para reuniones individuales durante todo el evento. Los inversores interesados pueden coordinar reuniones a través de sus representantes de Canaccord Genuity.
electroCore (Nasdaq: ECOR), 생물 전자 의학 및 웰니스 회사,는 Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum에 참여한다고 발표했습니다. 이 행사는 2024년 11월 21일 뉴욕에서 개최됩니다. Joshua Lev, 최고 재무 책임자,는 이벤트 기간 동안 일대일 회의에 참석할 예정입니다. 관심 있는 투자자는 Canaccord Genuity 대리인을 통해 회의를 조율할 수 있습니다.
electroCore (Nasdaq: ECOR), une entreprise de médecine bioélectronique et de bien-être, a annoncé sa participation au Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum le 21 novembre 2024 à New York. Joshua Lev, directeur financier, sera disponible pour des réunions individuelles tout au long de l'événement. Les investisseurs intéressés peuvent organiser des réunions par l'intermédiaire de leurs représentants Canaccord Genuity.
electroCore (Nasdaq: ECOR), ein Unternehmen für bioelektronische Medizin und Wohlbefinden, gab seine Teilnahme am Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum am 21. November 2024 in New York City bekannt. Joshua Lev, Chief Financial Officer, steht während der gesamten Veranstaltung für Einzelgespräche zur Verfügung. Interessierte Investoren können über ihre Canaccord Genuity-Vertreter Treffen vereinbaren.
- None.
- None.
ROCKAWAY, N.J., Nov. 14, 2024 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum taking place in New York City on November 21, 2024.
Joshua Lev, Chief Financial Officer, will host one-on-one meetings throughout the day.
To schedule a one-on-one meeting with Mr. Lev, investors are encouraged to reach out to their CG representative. For more information regarding the event please visit https://www.meetmax.com/sched/event_110807/conference_home.html.
About electroCore, Inc.
electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization of medical devices for the management and treatment of certain medical conditions and consumer product offerings utilizing nVNS to promote general wellbeing and human performance in the United States and select overseas markets.
For more information, visit www.electrocore.com.
Contact
ECOR Investor Relations
(973) 302-9253
investors@electrocore.com
FAQ
When is electroCore (ECOR) participating in the Canaccord Genuity MedTech Forum?
Who will represent electroCore (ECOR) at the Canaccord Genuity Forum?
How can investors schedule meetings with electroCore (ECOR) at the Canaccord Forum?